Adeniyi Thompson Adewumi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Adeniyi Thompson Adewumi has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Salerwe Mosebi
Department of Life and Consumer Sciences, Calabash Building, Room 02-026, University of South Africa, Johannesburg, South Africa
9 shared publications - Mahmoud E. S. Soliman
Molecular Bio-computation and Drug Design Laboratory, School of Health Sciences, University of KwaZulu-Natal, Westville Campus, Durban 4000, South Africa
8 shared publications - Wande Michael Oluyemi
Department of Pharmaceutical and Medicinal Chemistry, College of Pharmacy, Afe Babalola University, Ado-Ekiti, Nigeria
8 shared publications - Shadrach Chinecherem Eze
Department of Pharmaceutical and Medicinal Chemistry, College of Pharmacy, Afe Babalola University, Ado-Ekiti, Nigeria
6 shared publications - Yemi Adekola Adekunle
Department of Pharmaceutical and Medicinal Chemistry, College of Pharmacy, Afe Babalola University, Ado-Ekiti, Nigeria
4 shared publications - Babatunde B. Samuel
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ibadan, Nigeria
3 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by MDPI AG in Preprints.org
Towards New Antidiabetic Development: Molecular Interactions Unfold Potential Agonistic Mechanisms of Naturally Occurring Terpenoids Against Structural Landscape of Glucagon-like Peptide-1 Receptor
Glucagon-like peptide-1 receptor (GLP-1R) is a focal target in antidiabetic drug discovery. Synthetic non-peptide compounds are routinely employed to investigate GLP-1R, however, scaffolds from natural products will offer us unique structural diversity to design more potent compounds. We investigated the potential of some natural compounds as agonists of GLP-1R. First, we carried out a virtual screening of 244 compounds, from 19 medicinal plants used in antidiabetic traditional medicine, against GLP-1R. We used molecular dynamics simulations, for 200ns, to further investigate the lead five compounds. Binding Free Energies (BFE), Root Mean Square Deviation (RMSD) and other parameters were employed to understand these interactions. Our results showed that lupeol (-57.23) had good BFE (kcal/mol) compared to danuglipron (-56.47), thus demonstrating more robust interactions with GLP-1R. The pocket-buried residues, CYS191 and GLN186, showed strong hydrogen bonds while the critical residue, TRP4, showed strong van der Waals interactions to stabilize the ligands. Moreover, the average RMSD (Å) of lupeol-bound GLP-1R (3.45) are comparable to danuglipron-bound GLP-1R (3.33), indicating good stability in the pocket. This potentially situates lupeol as GLP-1R agonist similar to danuglipron, and thus opens up the opportunity for more further experimental work, to validate its agonist properties on GLP1R.
- 3 November 2026
- Published by MDPI AG in Preprints.org
Open AccessTowards New Antidiabetic Development: Molecular Interactions Unfold Potential Agonistic Mechanisms of Naturally Occurring Terpenoids Against Structural Landscape of Glucagon-like Peptide-1 Receptor
Glucagon-like peptide-1 receptor (GLP-1R) is a focal target in antidiabetic drug discovery. Synthetic non-peptide compounds are routinely employed to investigate GLP-1R, however, scaffolds from natural products will offer us unique structural diversity to design more potent compounds. We investigated the potential of some natural compounds as agonists of GLP-1R. First, we carried out a virtual screening of 244 compounds, from 19 medicinal plants used in antidiabetic traditional medicine, against GLP-1R. We used molecular dynamics simulations, for 200ns, to further investigate the lead five compounds. Binding Free Energies (BFE), Root Mean Square Deviation (RMSD) and other parameters were employed to understand these interactions. Our results showed that lupeol (-57.23) had good BFE (kcal/mol) compared to danuglipron (-56.47), thus demonstrating more robust interactions with GLP-1R. The pocket-buried residues, CYS191 and GLN186, showed strong hydrogen bonds while the critical residue, TRP4, showed strong van der Waals interactions to stabilize the ligands. Moreover, the average RMSD (Å) of lupeol-bound GLP-1R (3.45) are comparable to danuglipron-bound GLP-1R (3.33), indicating good stability in the pocket. This potentially situates lupeol as GLP-1R agonist similar to danuglipron, and thus opens up the opportunity for more further experimental work, to validate its agonist properties on GLP1R.
- Open Access
- 27 October 2026
- Published by MDPI AG in Preprints.org
Beyond Arbitrary Selection: A Multi‐Target Virtual Screening Framework to Reveal Antimalarial Potential of Natural Products Against Plasmodium falciparum PKG and MAP
Molecular docking (MD) have improved our understanding of how bioactive natural products (NPs) interact with Plasmodium Falciparum targets, to elicit their pharmacological actions. MD is done by selecting a few molecular targets, and placing them in the active site, to discover the most affinity-favoured compounds. However, the number of proteins selected for such MD influence ones assertion about the possible binding targets of the NPs under study. Using few protein targets limits docking score comparisons, which is the basis for the identification of potential multi-target NPs for antimalaria therapy. In addition, docking without molecular dynamics simulations (MDS), limits insights about the flexibility of target-ligand interactions in real biological systems. We had proposed multi-target virtual screening (with number of proteins => 10) as a prerequisite in studies evaluating potential binding targets of NPs. This, followed by distribution plots and or heatmap plots, can help prioritize targets and ligands for further MDS and then experimental validation. Using this strategy, we docked 1000+ NPs against 18 high-priority Plasmodium falciparum targets to select high-affinity binders, including compound C761 with multi-target potential against PfPKG and PfMAP. Though binding free energy from MDS did not correlate with docking scores, other results like RMSD, ROG and PCA suggest favourable conformational changes that can be explored for possible dual inhibition of PfPKG and PfAAP by C761. Our study provides a baseline framework to help researchers design better virtual screening workflows in elucidating molecular targets of natural products against Plasmodium falciparum.
- 27 October 2026
- Published by MDPI AG in Preprints.org
Open AccessBeyond Arbitrary Selection: A Multi‐Target Virtual Screening Framework to Reveal Antimalarial Potential of Natural Products Against Plasmodium falciparum PKG and MAP
Molecular docking (MD) have improved our understanding of how bioactive natural products (NPs) interact with Plasmodium Falciparum targets, to elicit their pharmacological actions. MD is done by selecting a few molecular targets, and placing them in the active site, to discover the most affinity-favoured compounds. However, the number of proteins selected for such MD influence ones assertion about the possible binding targets of the NPs under study. Using few protein targets limits docking score comparisons, which is the basis for the identification of potential multi-target NPs for antimalaria therapy. In addition, docking without molecular dynamics simulations (MDS), limits insights about the flexibility of target-ligand interactions in real biological systems. We had proposed multi-target virtual screening (with number of proteins => 10) as a prerequisite in studies evaluating potential binding targets of NPs. This, followed by distribution plots and or heatmap plots, can help prioritize targets and ligands for further MDS and then experimental validation. Using this strategy, we docked 1000+ NPs against 18 high-priority Plasmodium falciparum targets to select high-affinity binders, including compound C761 with multi-target potential against PfPKG and PfMAP. Though binding free energy from MDS did not correlate with docking scores, other results like RMSD, ROG and PCA suggest favourable conformational changes that can be explored for possible dual inhibition of PfPKG and PfAAP by C761. Our study provides a baseline framework to help researchers design better virtual screening workflows in elucidating molecular targets of natural products against Plasmodium falciparum.
- Open Access
- 17 October 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (10) , 2366
Computational Analysis of the Homologous Mouse Double RINGs Interface for Targeted Anticancer Drug Design
Background/Objectives: The new yearly 1.1 million cancer cases and considerably increasing mortality, after decades of decline, require urgent and effective therapy. Targeted anticancer therapy is an attractive strategy for treating cancer by targeting critical receptors. The MDM2-MDMX RING heterodimer downregulates the p53 tumor suppressor pathway, making its disruption a primary therapeutic strategy in oncology. This study evaluates a series of novel inhibitors against the MDM2-MDMX RING interface to identify potent candidates that overcome the binding affinity and structural stability limitations of current small-molecule options like HLI373. Methods: Comprehensive computational simulations and MM/PBSA energy calculations were performed on five inhibitor complexes: Hinokiflavone, MMRi62, MMRi64, MMRi71, and HLI373. Structural stability, flexibility, and compactness were rigorously analyzed across a 200 ns molecular dynamics simulation trajectory using Root Mean Square Deviation (RMSD) and Root Mean Square Fluctuation (RMSF) metrics alongside Principal Component Analysis. Results: Among the evaluated MDM2-MDMX dual inhibitors, MMRi62 demonstrated the strongest binding affinity with a ΔGbind of −26.42 kcal/mol, outperforming reference HLI373 (−14.09 kcal/mol), Hinokiflavone (−22.69 kcal/mol), and MMRi64 (−16.73 kcal/mol). Structurally, MMRi64-bound complexes exhibited the highest stability, achieving the lowest RMSD of 2.28 Å and RMSF of 1.30 Å. Conversely, HLI373-bound complexes displayed pronounced structural fluctuations, yielding a high RMSD of 5.11 Å. Conclusions: These inhibitors present highly promising alternatives to HLI373 for targeting the MDM2-MDMX RING interface. MMRi62 and Hinokiflavone, in particular, stand out as highly potent dual-inhibitor leads for future targeted anticancer therapy development.
- 17 October 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (10) , 2366
Open AccessComputational Analysis of the Homologous Mouse Double RINGs Interface for Targeted Anticancer Drug Design
Background/Objectives: The new yearly 1.1 million cancer cases and considerably increasing mortality, after decades of decline, require urgent and effective therapy. Targeted anticancer therapy is an attractive strategy for treating cancer by targeting critical receptors. The MDM2-MDMX RING heterodimer downregulates the p53 tumor suppressor pathway, making its disruption a primary therapeutic strategy in oncology. This study evaluates a series of novel inhibitors against the MDM2-MDMX RING interface to identify potent candidates that overcome the binding affinity and structural stability limitations of current small-molecule options like HLI373. Methods: Comprehensive computational simulations and MM/PBSA energy calculations were performed on five inhibitor complexes: Hinokiflavone, MMRi62, MMRi64, MMRi71, and HLI373. Structural stability, flexibility, and compactness were rigorously analyzed across a 200 ns molecular dynamics simulation trajectory using Root Mean Square Deviation (RMSD) and Root Mean Square Fluctuation (RMSF) metrics alongside Principal Component Analysis. Results: Among the evaluated MDM2-MDMX dual inhibitors, MMRi62 demonstrated the strongest binding affinity with a ΔGbind of −26.42 kcal/mol, outperforming reference HLI373 (−14.09 kcal/mol), Hinokiflavone (−22.69 kcal/mol), and MMRi64 (−16.73 kcal/mol). Structurally, MMRi64-bound complexes exhibited the highest stability, achieving the lowest RMSD of 2.28 Å and RMSF of 1.30 Å. Conversely, HLI373-bound complexes displayed pronounced structural fluctuations, yielding a high RMSD of 5.11 Å. Conclusions: These inhibitors present highly promising alternatives to HLI373 for targeting the MDM2-MDMX RING interface. MMRi62 and Hinokiflavone, in particular, stand out as highly potent dual-inhibitor leads for future targeted anticancer therapy development.
- Open Access
- 6 October 2026
- Published by Elsevier in Protein Expression and Purification
- Vol. 244
Over-expression, purification, and characterisation of Mycobacterium tuberculosis MPT64 from inclusion bodies
- 6 October 2026
- Published by Elsevier in Protein Expression and Purification
- Vol. 244
Open AccessOver-expression, purification, and characterisation of Mycobacterium tuberculosis MPT64 from inclusion bodies
- Open Access
- 25 August 2026
- Published by MDPI AG in Preprints.org
Computational Analysis of the Homologous Mouse Double RINGs Interface for Targeted Anticancer Drug Design
The new yearly 1.1 million cancer surges and considerably increasing mortality, post-decades of decline, require urgent and effective therapy. Targeted anticancer therapy is an attractive strategy for treating cancer by targeting critical receptors. Homologous Mouse Double-Minute RINGs (MDM2-MDMX RING) negatively regulate the p53 tumour-suppressing role by promoting proteasomal degradation. Interventively, Hinok., MMRi62, MMRi64, and MMRi71 exert a therapeutic downregulation against MDM2-MDMX RING heterodimer by activating p53’s apoptotic arm, but their binding mechanisms remain poorly understood due to the RING domain’s high structural flexibility and lack of co-crystal structures. This study reveals the underlying dynamic conformational stability and flexibility of the MDM2G443T-MDMX interface, and the potential mechanistic inhibitor binding using the all-atom MD simulations. The MMRi64-bound and Hinok-bound systems exhibited the lowest RMSD values (2.28 Å and 2.34 Å, respectively), indicating significant protein stabilization. MMRi71-bound (1.03 Å) and MMRi64-bound (1.30 Å) complexes displayed the lowest mean RMSF values, demonstrating that these ligands lock the protein into a rigid conformation. Conversely, the MMRi62-bound system showed the highest average RMSD and the highest RMSF (1.74 Å), identifying it as the most flexible complex. The ligand-bound MDM2G443T-MDMX complex underwent notable secondary structure transitions. MMGB/PBSA calculations revealed favorable binding free energies (-22.69, -26.42, and -20.30 kcal/mol) for the key interactions. Arg444, Pro445, Lys473, and Pro476 provided the highest binding free energy contributions to the RING domains. Over the 200 ns simulation, Hinok demonstrated dual interactions with both MDM2G443T-MDMX RING domains, highlighting a potential dual-inhibition mechanism, whereas MMRis interacted selectively with MDM2.
- 25 August 2026
- Published by MDPI AG in Preprints.org
Open AccessComputational Analysis of the Homologous Mouse Double RINGs Interface for Targeted Anticancer Drug Design
The new yearly 1.1 million cancer surges and considerably increasing mortality, post-decades of decline, require urgent and effective therapy. Targeted anticancer therapy is an attractive strategy for treating cancer by targeting critical receptors. Homologous Mouse Double-Minute RINGs (MDM2-MDMX RING) negatively regulate the p53 tumour-suppressing role by promoting proteasomal degradation. Interventively, Hinok., MMRi62, MMRi64, and MMRi71 exert a therapeutic downregulation against MDM2-MDMX RING heterodimer by activating p53’s apoptotic arm, but their binding mechanisms remain poorly understood due to the RING domain’s high structural flexibility and lack of co-crystal structures. This study reveals the underlying dynamic conformational stability and flexibility of the MDM2G443T-MDMX interface, and the potential mechanistic inhibitor binding using the all-atom MD simulations. The MMRi64-bound and Hinok-bound systems exhibited the lowest RMSD values (2.28 Å and 2.34 Å, respectively), indicating significant protein stabilization. MMRi71-bound (1.03 Å) and MMRi64-bound (1.30 Å) complexes displayed the lowest mean RMSF values, demonstrating that these ligands lock the protein into a rigid conformation. Conversely, the MMRi62-bound system showed the highest average RMSD and the highest RMSF (1.74 Å), identifying it as the most flexible complex. The ligand-bound MDM2G443T-MDMX complex underwent notable secondary structure transitions. MMGB/PBSA calculations revealed favorable binding free energies (-22.69, -26.42, and -20.30 kcal/mol) for the key interactions. Arg444, Pro445, Lys473, and Pro476 provided the highest binding free energy contributions to the RING domains. Over the 200 ns simulation, Hinok demonstrated dual interactions with both MDM2G443T-MDMX RING domains, highlighting a potential dual-inhibition mechanism, whereas MMRis interacted selectively with MDM2.
- Open Access
- 2 June 2026
- Published by MDPI AG in Biophysica
- Vol. 6 (3) , 47
Revisiting BACE-1: How Machine Learning and Molecular Dynamics Unveiled Potential Anti-Alzheimer’s Activity of a Cysteinyl Sulfoxide Derivative
Beta Secretase (BACE1) is a well-validated target for Alzheimer’s therapies, but there has been attrition in drug development. Herein, we leveraged machine learning (ML), virtual screening and molecular dynamics (MD) to identify novel compounds with potential activity against BACE1. We developed ML algorithms to distinguish active and inactive compounds from public databases. Molecular docking and dynamics were used to explore the inhibition mechanism, thermodynamic stability, and the flap dynamics of the BACE1-ligand complexes. Random Forest Classifier (RF) showed excellent metrics (accuracy: 0.9807; F1 score: 0.9804; specificity 0.9977), compared to other models. Molecular docking with predicted actives revealed compounds BA1, BA2, and BA3 with strong affinity for BACE1. Compound BA2, a cysteinyl sulfoxide derivative, showed good stability (RMSD) during simulations (1.307 ± 0.109 Å) compared to Verubecestat (1.602 ± 0.159 Å). MMGBSA-based binding free energy (ΔGbind; kcal/mol) showed that BA2 (−33.820 ± 4.254) had comparatively lower energy than Verubecestat (−21.090 ± 6.183). BA2 maintained electrostatic interactions with the catalytic dyad (Asp36 and Asp232) and Thr76 of the flap. BA2 also maintained the flaps in a semi-open conformation (d0: 11.807 ± 0.401 Å) throughout the simulation. Our study clearly demonstrates the utility of ML in prioritization of compounds before molecular docking and MD in early phases of drug discovery.
- 2 June 2026
- Published by MDPI AG in Biophysica
- Vol. 6 (3) , 47
Open AccessRevisiting BACE-1: How Machine Learning and Molecular Dynamics Unveiled Potential Anti-Alzheimer’s Activity of a Cysteinyl Sulfoxide Derivative
Beta Secretase (BACE1) is a well-validated target for Alzheimer’s therapies, but there has been attrition in drug development. Herein, we leveraged machine learning (ML), virtual screening and molecular dynamics (MD) to identify novel compounds with potential activity against BACE1. We developed ML algorithms to distinguish active and inactive compounds from public databases. Molecular docking and dynamics were used to explore the inhibition mechanism, thermodynamic stability, and the flap dynamics of the BACE1-ligand complexes. Random Forest Classifier (RF) showed excellent metrics (accuracy: 0.9807; F1 score: 0.9804; specificity 0.9977), compared to other models. Molecular docking with predicted actives revealed compounds BA1, BA2, and BA3 with strong affinity for BACE1. Compound BA2, a cysteinyl sulfoxide derivative, showed good stability (RMSD) during simulations (1.307 ± 0.109 Å) compared to Verubecestat (1.602 ± 0.159 Å). MMGBSA-based binding free energy (ΔGbind; kcal/mol) showed that BA2 (−33.820 ± 4.254) had comparatively lower energy than Verubecestat (−21.090 ± 6.183). BA2 maintained electrostatic interactions with the catalytic dyad (Asp36 and Asp232) and Thr76 of the flap. BA2 also maintained the flaps in a semi-open conformation (d0: 11.807 ± 0.401 Å) throughout the simulation. Our study clearly demonstrates the utility of ML in prioritization of compounds before molecular docking and MD in early phases of drug discovery.
- Open Access
- 23 March 2026
- Published by MDPI AG in Preprints.org
Revisiting BACE-1: How Machine Learning and Molecular Dynamics Unveiled Potential Anti-Alzheimer’s Activity of a Cysteinyl Sulfoxide Derivative
Beta Secretase (BACE-1) is a well-validated target for Alzheimer’s therapies, but have seen attrition in drug development. Herein, we leveraged machine learning (ML), virtual screening and molecular dynamics (MD) to identify novel compounds with potential activity against BACE1. We developed ML algorithms to distinguish active and inactive compounds from public databases. Molecular docking and MD (250ns) was used to explore the inhibition mechanism, thermodynamic stability, and the flap dynamics of the BACE1-ligand complexes. Random Forest Classifier (RF) showed excellent metrics (accuracy: 0.9807; F1 score: 0.9804; specificity 0.9977), compared to other models. Molecular docking with predicted actives revealed compounds BA1, BA2, and BA3 with strong affinity for the BACE1. Compound BA2, a cysteinyl sulfoxide derivative, showed good stability (RMSD) during simulations (1.307±0.109 Å) compared to Verubecestat (1.602±0.159Å). MMGBSA-based binding free energy (ΔGbind; kcal/mol) showed that BA2 (-33.820±4.254) had comparatively lower energy than Verubecestat (-21.090±6.183). BA2 maintained electrostatic interactions with the catalytic dyad (Asp36 & Asp232) and Thr76 of the flap. BA2 also maintained the flaps in a semi-open conformation (d0: 11.807 ± 0.401 Å) throughout the simulation. Our study clearly demonstrate the utility of ML in prioritization of compounds before molecular docking and MD in early phases of drug discovery.
- 23 March 2026
- Published by MDPI AG in Preprints.org
Open AccessRevisiting BACE-1: How Machine Learning and Molecular Dynamics Unveiled Potential Anti-Alzheimer’s Activity of a Cysteinyl Sulfoxide Derivative
Beta Secretase (BACE-1) is a well-validated target for Alzheimer’s therapies, but have seen attrition in drug development. Herein, we leveraged machine learning (ML), virtual screening and molecular dynamics (MD) to identify novel compounds with potential activity against BACE1. We developed ML algorithms to distinguish active and inactive compounds from public databases. Molecular docking and MD (250ns) was used to explore the inhibition mechanism, thermodynamic stability, and the flap dynamics of the BACE1-ligand complexes. Random Forest Classifier (RF) showed excellent metrics (accuracy: 0.9807; F1 score: 0.9804; specificity 0.9977), compared to other models. Molecular docking with predicted actives revealed compounds BA1, BA2, and BA3 with strong affinity for the BACE1. Compound BA2, a cysteinyl sulfoxide derivative, showed good stability (RMSD) during simulations (1.307±0.109 Å) compared to Verubecestat (1.602±0.159Å). MMGBSA-based binding free energy (ΔGbind; kcal/mol) showed that BA2 (-33.820±4.254) had comparatively lower energy than Verubecestat (-21.090±6.183). BA2 maintained electrostatic interactions with the catalytic dyad (Asp36 & Asp232) and Thr76 of the flap. BA2 also maintained the flaps in a semi-open conformation (d0: 11.807 ± 0.401 Å) throughout the simulation. Our study clearly demonstrate the utility of ML in prioritization of compounds before molecular docking and MD in early phases of drug discovery.
- Open Access
- 26 June 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (13) , 6142
Hepatoprotective and Nephroprotective Effects of Leea guineensis Leaf Extract Against Paracetamol-Induced Toxicity: Combined Mouse Model-Integrated in Silico Evidence
Acetaminophen, or paracetamol (PCM), is a common painkiller used to treat aches, pain, and fever. Nevertheless, PCM has been reported to be hepatotoxic and nephrotoxic in humans. Thus, there is a need to identify how this side effect can be treated. Previous studies have shown that Leea species possess antioxidative, anthelmintic, anti-cytotoxic, hepatoprotective, and nephroprotective properties. However, the role of Leea guineensis (LG) in modulating PCM-induced hepatotoxicity or nephrotoxicity remains unknown. Herein, we investigate the possibility of Leea guineensis leaf extract (LGE) to ameliorate PCM toxic effects, evaluate hepatic and renal function, oxidative stress markers, and safety, and perform molecular docking to predict affinities of Leea guineensis extract compounds for their targets compared to PCM. An in vivo rat model was used for Leea guineensis extract or silymarin (SLM, standard drug) at various concentrations, and it was co-administered with PCM. We observed that Leea guineensis extract is rich in phytochemical constituents, and its treatment in rats did not significantly affect body weight. Our data showed that PCM increased bilirubin, creatinine, uric acid, Alanine aminotransferase (ALT), and cholesterol levels but decreased Aspartate aminotransferase (AST) in plasma. Moreover, it increased lipid peroxidation (MDA) levels in the liver and kidneys, while the total protein was elevated in the latter. Interestingly, Leea guineensis extract and SLM abrogated the elevated parameters due to PCM toxicity. Importantly, histopathological examination showed that Leea guineensis extract demonstrated the potential to ameliorate hepatic and renal lesions caused by PCM intoxication, thus demonstrating its safety. Furthermore, comparative molecular binding affinities of the study ligands binding the target corroborate the experimental findings. Our study shows that L. guineensis leaf extract, through its rich phytochemicals, can protect the liver and kidneys against the toxic effects of paracetamol in a dose-dependent manner.
- 26 June 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (13) , 6142
Open AccessHepatoprotective and Nephroprotective Effects of Leea guineensis Leaf Extract Against Paracetamol-Induced Toxicity: Combined Mouse Model-Integrated in Silico Evidence
Acetaminophen, or paracetamol (PCM), is a common painkiller used to treat aches, pain, and fever. Nevertheless, PCM has been reported to be hepatotoxic and nephrotoxic in humans. Thus, there is a need to identify how this side effect can be treated. Previous studies have shown that Leea species possess antioxidative, anthelmintic, anti-cytotoxic, hepatoprotective, and nephroprotective properties. However, the role of Leea guineensis (LG) in modulating PCM-induced hepatotoxicity or nephrotoxicity remains unknown. Herein, we investigate the possibility of Leea guineensis leaf extract (LGE) to ameliorate PCM toxic effects, evaluate hepatic and renal function, oxidative stress markers, and safety, and perform molecular docking to predict affinities of Leea guineensis extract compounds for their targets compared to PCM. An in vivo rat model was used for Leea guineensis extract or silymarin (SLM, standard drug) at various concentrations, and it was co-administered with PCM. We observed that Leea guineensis extract is rich in phytochemical constituents, and its treatment in rats did not significantly affect body weight. Our data showed that PCM increased bilirubin, creatinine, uric acid, Alanine aminotransferase (ALT), and cholesterol levels but decreased Aspartate aminotransferase (AST) in plasma. Moreover, it increased lipid peroxidation (MDA) levels in the liver and kidneys, while the total protein was elevated in the latter. Interestingly, Leea guineensis extract and SLM abrogated the elevated parameters due to PCM toxicity. Importantly, histopathological examination showed that Leea guineensis extract demonstrated the potential to ameliorate hepatic and renal lesions caused by PCM intoxication, thus demonstrating its safety. Furthermore, comparative molecular binding affinities of the study ligands binding the target corroborate the experimental findings. Our study shows that L. guineensis leaf extract, through its rich phytochemicals, can protect the liver and kidneys against the toxic effects of paracetamol in a dose-dependent manner.
- Open Access
- 11 December 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (24) , 13310
Helichrysum populifolium Compounds Inhibit MtrCDE Efflux Pump Transport Protein for the Potential Management of Gonorrhoea Infection
The progressive development of resistance in Neisseria gonorrhoeae to almost all available antibiotics has made it crucial to develop novel approaches to tackling multi-drug resistance (MDR). One of the primary causes of antibiotic resistance is the over-expression of the MtrCDE efflux pump protein, making this protein a vital target for fighting against antimicrobial resistance (AMR) in N. gonorrhoeae. This study was aimed at evaluating the potential MtrCDE efflux pump inhibitors (EPIs) and their stability in treating gonorrhoea infection. This is significant because finding novel EPIs would allow for the longer maintenance of antibiotics at therapeutic levels, thereby prolonging the susceptibility of currently available antibiotics. A virtual screening of the selected Helichrysum populifolium compounds (4,5-dicaffeoylquinic acid, apigeninin-7-glucoside, and carvacrol) was conducted to evaluate their potential EPI activity. An integrated computational framework consisting of molecular docking (MD), molecular mechanics generalized born, and surface area solvation (MMGBSA) analysis, molecular dynamics simulations (MDS), and absorption, distribution, metabolism, and excretion (ADME) properties calculations were conducted. Of the tested compounds, 4,5-dicaffeoylquinic acid revealed the highest molecular docking binding energies (−8.8 kcal/mol), equivalent MMGBSA binding free energy (−54.82 kcal/mol), indicative of consistent binding affinity with the MtrD protein, reduced deviations and flexibility (root mean square deviation (RMSD) of 5.65 Å) and, given by root mean square fluctuation (RMSF) of 1.877 Å. Carvacrol revealed a docking score of −6.0 kcal/mol and a MMGBSA computed BFE of −16.69 kcal/mol, demonstrating the lowest binding affinity to the MtrD efflux pump compared to the remaining test compounds. However, the average RMSD (4.45 Å) and RMSF (1.638 Å) of carvacrol-bound MtrD protein showed no significant difference from the unbound MtrD protein, except for the reference compounds, implying consistent MtrD conformation throughout simulations and indicates a desirable feature during drug design. Additionally, carvacrol obeyed the Lipinski rule of five which confirmed the compound’s drug-likeness properties making it the most promising EPI candidate based on its combined attributes of a reasonable binding affinity, sustained stability during MDS, its obedience to the Lipinski rule of five and compliance with drug-likeness criteria. An in vitro validation of the potential EPI activities of H. populifolium compounds confirmed that 4,5-dicaffeoylquinic acid reduced the expulsion of the bis-benzimide dye by MtrCDE pump, while carvacrol showed low accumulation compared to other compounds. While 4,5-dicaffeoylquinic acid demonstrated the highest binding affinity in computational analysis and an EPI activity in vitro, it showed lower stability compared to the other compounds, as indicated in MDS. This leaves carvacrol, as a better EPI candidate for the management of gonorrhoea infection.
- 11 December 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (24) , 13310
Open AccessHelichrysum populifolium Compounds Inhibit MtrCDE Efflux Pump Transport Protein for the Potential Management of Gonorrhoea Infection
The progressive development of resistance in Neisseria gonorrhoeae to almost all available antibiotics has made it crucial to develop novel approaches to tackling multi-drug resistance (MDR). One of the primary causes of antibiotic resistance is the over-expression of the MtrCDE efflux pump protein, making this protein a vital target for fighting against antimicrobial resistance (AMR) in N. gonorrhoeae. This study was aimed at evaluating the potential MtrCDE efflux pump inhibitors (EPIs) and their stability in treating gonorrhoea infection. This is significant because finding novel EPIs would allow for the longer maintenance of antibiotics at therapeutic levels, thereby prolonging the susceptibility of currently available antibiotics. A virtual screening of the selected Helichrysum populifolium compounds (4,5-dicaffeoylquinic acid, apigeninin-7-glucoside, and carvacrol) was conducted to evaluate their potential EPI activity. An integrated computational framework consisting of molecular docking (MD), molecular mechanics generalized born, and surface area solvation (MMGBSA) analysis, molecular dynamics simulations (MDS), and absorption, distribution, metabolism, and excretion (ADME) properties calculations were conducted. Of the tested compounds, 4,5-dicaffeoylquinic acid revealed the highest molecular docking binding energies (−8.8 kcal/mol), equivalent MMGBSA binding free energy (−54.82 kcal/mol), indicative of consistent binding affinity with the MtrD protein, reduced deviations and flexibility (root mean square deviation (RMSD) of 5.65 Å) and, given by root mean square fluctuation (RMSF) of 1.877 Å. Carvacrol revealed a docking score of −6.0 kcal/mol and a MMGBSA computed BFE of −16.69 kcal/mol, demonstrating the lowest binding affinity to the MtrD efflux pump compared to the remaining test compounds. However, the average RMSD (4.45 Å) and RMSF (1.638 Å) of carvacrol-bound MtrD protein showed no significant difference from the unbound MtrD protein, except for the reference compounds, implying consistent MtrD conformation throughout simulations and indicates a desirable feature during drug design. Additionally, carvacrol obeyed the Lipinski rule of five which confirmed the compound’s drug-likeness properties making it the most promising EPI candidate based on its combined attributes of a reasonable binding affinity, sustained stability during MDS, its obedience to the Lipinski rule of five and compliance with drug-likeness criteria. An in vitro validation of the potential EPI activities of H. populifolium compounds confirmed that 4,5-dicaffeoylquinic acid reduced the expulsion of the bis-benzimide dye by MtrCDE pump, while carvacrol showed low accumulation compared to other compounds. While 4,5-dicaffeoylquinic acid demonstrated the highest binding affinity in computational analysis and an EPI activity in vitro, it showed lower stability compared to the other compounds, as indicated in MDS. This leaves carvacrol, as a better EPI candidate for the management of gonorrhoea infection.
- Open Access
- 1 November 2024
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 43 (14) , 7949-7962
Oleanolic acid purified from the stem bark of Olax subscorpioidea Oliv. inhibits the function and catalysis of human 17 β -hydroxysteroid dehydrogenase 1
Cancer is a leading cause of global death. Medicinal plants have gained increasing attention in cancer drug discovery. In this study, the stem bark extract of Olax subscorpioidea, which is used in ethnomedicine to treat cancer, was subjected to phytochemical investigation leading to the isolation of oleanolic acid (OA). The structure was elucidated by 1-dimensional and 2-dimensional nuclear magnetic resonance spectroscopic (NMR) data, and by comparing its data with previously reported data. Molecular docking was used to investigate the interactions of OA with nine selected cancer-related protein targets. OA docked well with human 17β-hydroxysteroid dehydrogenase type-1 (17βHSD1), caspase-3, and epidermal growth factor receptor tyrosine kinase (binding affinities: -9.8, -9.3, and -9.1 kcal/mol, respectively). OA is a triterpenoid compound with structural similarity to steroids. This similarity with the substrates of 17βHSD1 gives the inhibitor candidate an excellent opportunity to bind to 17βHSD1. The structural and functional dynamics of OA-17βHSD1 were investigated by molecular dynamics simulations at 240 ns. Molecular mechanics/Poisson-Boltzmann surface area (MMPBSA) studies showed that OA had a binding free energy that is comparable with that of vincristine (-52.76, and -63.56 kcal/mol, respectively). The average C-α root mean square of deviation (RMSD) value of OA (1.69 Å) compared with the unbound protein (2.01 Å) indicated its high stability at the protein's active site. The binding energy and stability at the active site of 17βHSD1 recorded in this study indicate that OA exhibited profound inhibitory potential. OA could be a good scaffold for developing new anti-breast cancer drugs.
- 1 November 2024
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 43 (14) , 7949-7962
Open AccessOleanolic acid purified from the stem bark of Olax subscorpioidea Oliv. inhibits the function and catalysis of human 17 β -hydroxysteroid dehydrogenase 1
Cancer is a leading cause of global death. Medicinal plants have gained increasing attention in cancer drug discovery. In this study, the stem bark extract of Olax subscorpioidea, which is used in ethnomedicine to treat cancer, was subjected to phytochemical investigation leading to the isolation of oleanolic acid (OA). The structure was elucidated by 1-dimensional and 2-dimensional nuclear magnetic resonance spectroscopic (NMR) data, and by comparing its data with previously reported data. Molecular docking was used to investigate the interactions of OA with nine selected cancer-related protein targets. OA docked well with human 17β-hydroxysteroid dehydrogenase type-1 (17βHSD1), caspase-3, and epidermal growth factor receptor tyrosine kinase (binding affinities: -9.8, -9.3, and -9.1 kcal/mol, respectively). OA is a triterpenoid compound with structural similarity to steroids. This similarity with the substrates of 17βHSD1 gives the inhibitor candidate an excellent opportunity to bind to 17βHSD1. The structural and functional dynamics of OA-17βHSD1 were investigated by molecular dynamics simulations at 240 ns. Molecular mechanics/Poisson-Boltzmann surface area (MMPBSA) studies showed that OA had a binding free energy that is comparable with that of vincristine (-52.76, and -63.56 kcal/mol, respectively). The average C-α root mean square of deviation (RMSD) value of OA (1.69 Å) compared with the unbound protein (2.01 Å) indicated its high stability at the protein's active site. The binding energy and stability at the active site of 17βHSD1 recorded in this study indicate that OA exhibited profound inhibitory potential. OA could be a good scaffold for developing new anti-breast cancer drugs.